基于肠道微生物群的对帕金森病的干预:神经保护机制和当前的前景
Deepak Kumar1, Mahendra Bishnoi2, Kanthi Kiran Kondepudi2
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, 160062, India.
Probiotics and antimicrobial proteins
|January 14, 2025
概括
肠道微生物群干预措施通过恢复肠道健康和保护大脑细胞,对帕金森病 (PD) 是有前途的. 这些疗法调节肠道代谢物并激活神经保护通路,为PD患者提供潜在的益处.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 越来越多的证据将肠道微生物群失调与像帕金森病 (PD) 这样的神经退行性疾病联系起来.
- 基于肠道微生物群的干预措施 (前生菌,益生菌,共生菌,后生菌,便微生物群移植) 正在成为PD的潜在治疗策略.
研究的目的:
- 在帕金森病中审查基于肠道微生物群的干预措施的神经保护机制.
- 探索肠道代谢物和信号通路在调解这些影响中的作用.
主要方法:
- 对PD肠道微生物群干预的临床前和临床研究的文献综述.
- 分析与这些干预相关的分子途径和生理效应.
主要成果:
- 干预措施调节肠道代谢物 (例如,SCFA,GLP-1),通过肠-大脑轴增强神经保护.
- 神经保护涉及诸如神经红蛋白增强,PI3K/AKT/mTOR和Nrf2/ARE通路激活,自和屏障完整性维护等机制.
- 临床研究表明,在胃肠道功能障碍和一些神经症状方面有好处,但运动症状的改善是轻微的.
结论:
- 肠道微生物群干预通过各种分子和细胞途径为PD提供了多方面的神经保护策略.
- 需要进一步的大规模临床试验来验证治疗效果,特别是对于PD的运动症状.
相关概念视频
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Gut-Brain Axis
249
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
249
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34


